Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.

Vertex has established itself as a frontrunner in the indirect tax automation space, serving over 4,800 customers, including more than 60% of the Fortune 500. The company’s solutions are utilized in ...

Let’s dig into the relative performance of Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers as we unravel the now-completed Q4 therapeutics earnings season. Over the next few years ...

Subtract a company’s current liabilities from its current assets to calculate working capital. A positive amount of working capital means that a company can meet its short-term liabilities and ...

In September 2023, the company had raised around $20 million (Rs 173.2 crore) in its Series B round of funding, led by Vertex Ventures. Fireside Ventures also participated in the round. In addition, ...

A backpacker detained in the US is back home in Wales after an emotional airport reunion, her father has confirmed. Becky Burke, 28, had been held in a US Immigration and Customs Enforcement (ICE ...

The expanded collaboration now allows Reddit to use Google’s Vertex AI, which enables users to build, deploy, and scale machine learning models and AI applications, the author notes. Easily ...

It’s one of those interesting moments in time.” Google launched Vertex AI way back in 2021 as a platform for developers to build machine learning services in the cloud. That was, of course ...

Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...

AbbVie is a Dividend King with an attractive valuation. Vertex Pharmaceuticals' growth should accelerate after two key FDA approvals. Kiniksa Pharmaceuticals arguably has a gold mine with its ...